India Brazil and South Africa trade opportunities for drugmakers

21 October 2007

The IBSA (India, Brazil and South Africa) Business Forum, held in Johannesburg, South Africa, has discussed the opportunities and problems of trade between the three countries. Habil Khorakiwala, the Federation of Indian Chambers of Commerce president, spoke out at the meeting about the opportunity for more trade, particularly in pharmaceutical products, between the three countries.

Mr Khorakiwala argued that although Brazil, India and South Africa each have a drug industry, there is room for trade in this sector because they do not turn out the same products, the AllAfrica news agency reported.

South Africa's Trade and Industry Minister, Mandisi Mpahlwa, who attended the tri-national business meeting, promised to deal with complaints about non-tariff obstructions to trade, including improving transport links between the three countries, as well as visas for business trips to South Africa.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight